Sphingolipids in Multiple Sclerosis.
- Published in:
- NeuroMolecular Medicine, 2010, v. 12, n. 4, p. 351, doi. 10.1007/s12017-010-8128-4
- By:
- Publication type:
- Article
Works matching IS 15351084 AND DT 2010 AND VI 12 AND IP 4
Results: 7
1
2
The Role of the Ceramide Acyl Chain Length in Neurodegeneration: Involvement of Ceramide Synthases.
- Published in:
- NeuroMolecular Medicine, 2010, v. 12, n. 4, p. 341, doi. 10.1007/s12017-010-8114-x
- By:
- Publication type:
- Article
3
Mammalian Neutral Sphingomyelinases: Regulation and Roles in Cell Signaling Responses.
- Published in:
- NeuroMolecular Medicine, 2010, v. 12, n. 4, p. 320, doi. 10.1007/s12017-010-8120-z
- By:
- Publication type:
- Article
4
An Introduction to Sphingolipid Metabolism and Analysis by New Technologies.
- Published in:
- NeuroMolecular Medicine, 2010, v. 12, n. 4, p. 306, doi. 10.1007/s12017-010-8132-8
- By:
- Publication type:
- Article
5
Alterations of the Sphingolipid Pathway in Alzheimer's Disease: New Biomarkers and Treatment Targets?
- Published in:
- NeuroMolecular Medicine, 2010, v. 12, n. 4, p. 331, doi. 10.1007/s12017-010-8121-y
- By:
- Publication type:
- Article
6
Sphingolipids in Neurodegeneration.
- Published in:
- NeuroMolecular Medicine, 2010, v. 12, n. 4, p. 301, doi. 10.1007/s12017-010-8135-5
- By:
- Publication type:
- Article
7
Pathology and Current Treatment of Neurodegenerative Sphingolipidoses.
- Published in:
- NeuroMolecular Medicine, 2010, v. 12, n. 4, p. 362, doi. 10.1007/s12017-010-8133-7
- By:
- Publication type:
- Article